NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $23,000 | -32.4% | 1,417 | -3.5% | 0.00% | – |
| Q2 2020 | $34,000 | -39.3% | 1,469 | -44.2% | 0.00% | – |
| Q1 2020 | $56,000 | 0.0% | 2,634 | 0.0% | 0.00% | – |
| Q4 2019 | $56,000 | +19.1% | 2,634 | 0.0% | 0.00% | – |
| Q3 2019 | $47,000 | -49.5% | 2,634 | -0.2% | 0.00% | – |
| Q2 2019 | $93,000 | +5.7% | 2,638 | 0.0% | 0.00% | – |
| Q1 2019 | $88,000 | +2.3% | 2,638 | +0.2% | 0.00% | – |
| Q4 2018 | $86,000 | +258.3% | 2,634 | +430.0% | 0.00% | – |
| Q2 2018 | $24,000 | -7.7% | 497 | +11.4% | 0.00% | – |
| Q1 2018 | $26,000 | 0.0% | 446 | 0.0% | 0.00% | – |
| Q4 2017 | $26,000 | +2500.0% | 446 | +643.3% | 0.00% | – |
| Q3 2016 | $1,000 | -95.7% | 60 | -97.2% | 0.00% | – |
| Q3 2015 | $23,000 | -14.8% | 2,169 | 0.0% | 0.00% | – |
| Q2 2015 | $27,000 | +17.4% | 2,169 | 0.0% | 0.00% | – |
| Q1 2015 | $23,000 | -30.3% | 2,169 | 0.0% | 0.00% | – |
| Q4 2014 | $33,000 | – | 2,169 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
| Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
| Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
| Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
| BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
| First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
| Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
| SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
| QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
| Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |